| Autor: |
Alesina, P. F., Kniazeva, P., Pinto, G., Pontin, A., Walz, M. K. |
| Předmět: |
|
| Zdroj: |
World Journal of Surgery; Jan2024, Vol. 48 Issue 1, p121-129, 9p |
| Abstrakt: |
Background: We analyze the long‐term outcome of surgery for Cushing's syndrome (CS) and the influence of the extent of surgical resection on the duration of postoperative cortisone substitution. Methods: One‐hundred forty‐one patients (129 female, 12 males; mean age: 45.7 ± 12.8 years) operated between January 2000 to June 2020 were included in the analysis. Patients suffered from manifest (124) or subclinical (17) CS due to benign unilateral adrenal neoplasia. All tumors were removed by the posterior retroperitoneoscopic approach. 105 patients had total (TA) and 36 partial (PA) adrenalectomies. All patients were discharged with ongoing corticosteroid supplementation therapy. Results: Follow‐up data could be obtained for 83 patients. Twenty‐four (1 male, 23 females; mean age 42.3 years) underwent PA and 59 TA (6 males, 53 females; mean age 44.6 years). Mean follow‐up time was 107 ± 68 months (range: 6–243 months). The median duration of postoperative corticosteroid therapy was 9.5 months after PA and 11 months after TA (p = 0.1). Significantly, more patients after total adrenalectomy required corticosteroid therapy for more than 24 months (25% vs. 4%; p = 0.03). Recurrent ipsilateral disease occurred in one case after partial adrenalectomy and was treated by completion adrenalectomy. A case of contralateral recurrence associated with subclinical Cushing's syndrome was observed after total adrenalectomy. Conclusions: The risk of local recurrence after partial adrenalectomy in CS is low. Cortical‐sparing surgery may shorten corticosteroid supplementation therapy after surgery. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text